
-
Rybakina outlasts Yastremska to reach WTA Montreal quarter-finals
-
Young seizes five-stroke lead at PGA Wyndham Championship
-
Rescuers recover body of trapped worker at Chile copper mine
-
Patrick Star and 'Drag Queen' crab: underwater robot live stream captivates Argentines
-
McLaughlin-Levrone wins 400m to seal World Championship berth
-
Khachanov downs Ruud to book ATP Toronto clash with Michelsen
-
Young Catholics give rock star welcome to Pope Leo at vigil
-
Yamashita's lead in Women's British Open cut to one shot
-
Rovanpera survives puncture to close in on home win in Finland Rally
-
Siraj strikes after Jaiswal helps India set England daunting target
-
Doncic inks three-year $165 mln Lakers extension
-
Hamilton feeling 'useless' after Hungarian GP qualifying flop
-
Elation as pope arrives by helicopter to open-air youth vigil in Rome
-
McLaren blown away by changing wind as Leclerc lands pole for Ferrari
-
Home hero Ferrand-Prevot in epic climb to Tour de France lead
-
Leclerc ends Ferrari barren run with stunning pole ahead of McLarens
-
Ferrari's Leclerc on pole for Hungarian GP
-
Jaiswal's hundred leaves England needing Oval-record chase to beat India
-
At open-air Church party, many thousands of young Catholics eagerly await pope
-
Schmidt hails 'grit and resilience' as his Wallabies upset Lions
-
Dmitry Medvedev: Russia's hawkish ex-president
-
Imperious Ledecky beats McIntosh to win 800m free thriller
-
Ledecky reigns over McIntosh as record-breaking US hit back at critics
-
Farrell says 'dream' Lions should be proud despite bitter defeat
-
Ledecky beats McIntosh to win 800m freestyle thriller
-
Fearless Wallabies stun weary Lions to win third Test 22-12
-
Jaiswal and Deep keep India in the hunt against England
-
Piastri edges Norris as McLaren dominate Hungarian GP final practice
-
US envoy meets Israeli hostage families in Tel Aviv
-
McKeown beats Smith again for world backstroke double
-
New dad McEvoy adds 'unreal' world swimming gold to Olympic title
-
Walsh completes world butterfly double in riposte to Phelps
-
Turkey starts supplying Azerbaijani gas to boost Syria's power output
-
Thousands of young Catholics converge for grand Pope Leo vigil
-
SpaceX Crew Dragon docks with International Space Station
-
US do talking in pool after Phelps, Lochte slam worlds performance
-
Up to a million young Catholics expected for grand Pope Leo vigil
-
New push to reach plastic polution pact
-
Second seed Fritz ends Canadian hopes at ATP Toronto Masters
-
Japan sweats through hottest July on record
-
Jefferson-Wooden, Bednarek blaze to 100m titles at US trials
-
Son Heung-min to leave Tottenham this summer after decade
-
Bid to relocate US Space Shuttle Discovery faces museum pushback
-
Academics warn Columbia University deal sets dangerous precedent
-
Sevastova topples Pegula to book date with Osaka, Swiatek advances in Montreal
-
Former Olympic champion Mu-Nikolayev fails in worlds bid
-
Sensible and steely: how Mexico's Sheinbaum has dealt with Trump
-
Young leads at weather-hit PGA Wyndham Championship
-
US sprint star Richardson out of trials following arrest
-
Rublev, Tiafoe sweat out three-set wins in Toronto
CMSC | 0.09% | 22.87 | $ | |
CMSD | 0.34% | 23.35 | $ | |
SCS | -1.47% | 10.18 | $ | |
BCC | -0.55% | 83.35 | $ | |
NGG | 1.99% | 71.82 | $ | |
SCU | 0% | 12.72 | $ | |
BTI | 1.23% | 54.35 | $ | |
GSK | 1.09% | 37.56 | $ | |
JRI | -0.23% | 13.1 | $ | |
RIO | -0.2% | 59.65 | $ | |
RBGPF | 0% | 74.94 | $ | |
BCE | 1.02% | 23.57 | $ | |
VOD | 1.37% | 10.96 | $ | |
RELX | -0.58% | 51.59 | $ | |
AZN | 1.16% | 73.95 | $ | |
RYCEF | 0.07% | 14.19 | $ | |
BP | -1.26% | 31.75 | $ |

Ozempic slimming craze sweeps Kosovo despite side effects
Kosovo influencer Tringa Kadriu sees the slimming drug Ozempic as a chance to shed excess pounds -- and she is not the only one in her Balkan nation, where more than half the population is overweight.
"I want to lose 15-16 kilos (33-35 pounds) in two months," Kadriu, 29, told AFP, "and then I'll continue with fitness".
Ozempic, approved in the United States to treat diabetes in 2017, has found an international market for people trying to lose weight.
Despite its cost, the drug has soared in popularity in Kosovo, a country of 1.7 million.
While Kosovo authorities have not sanctioned the drug's use for weight loss, they have noted their limited means to confront use of a drug widely available in the country.
Merita Emini-Sadiku, who heads the Kosovo university hospital's endocrinology clinic, said the cost of the drug had soared.
"The monthly dose used to be 75-80 euros ($85-91), while now it is 130-140 euros ($147-159), probably due to high demand," she said.
But she warned that "Ozempic has side effects that people are not aware of".
Ozempic use can potentially cause issues including thyroid cancer, pancreatitis, gastroparesis and bowel obstruction, according to the latest studies.
- 'Constant demand' -
Meant to treat Type 2 diabetes -- of which the WHO says Kosovo has lower than average levels -- the drug regulates blood sugar levels but also helps suppress hunger, leading to a lower calorie intake.
As a result, its potentially cancerous complications have done little to stem the drug's popularity or availability.
"I checked a lot of pharmacies in Kosovo and I noticed that Ozempic is very easy to get," said Kadriu, adding that pharmacists even suggested she gradually increase her dosage.
A worker at a pharmacy in the capital Pristina's downtown, who asked to remain anonymous, said she had trouble recalling when someone last came into her pharmacy to buy Ozempic with a diabetes prescription.
"But we have a constant demand for Ozempic without a prescription. You can guess why," she said.
Given its availability, Emini-Sadiku said authorities should exercise greater control over Ozempic's distribution.
But Bujar Vitija, a journalist specialising in health, said that would be tricky to achieve given Kosovo's poor health record-keeping.
"Unfortunately there is no data," Vitija said.
With 1,500 to 1,600 private pharmacies in Kosovo, the country's 20 pharmaceutical inspectors have their work cut out for them, he added.
- Ozempic 'every day' -
While Kosovo has lower levels of obesity than the European average, more than 57 percent of the population is overweight and 20 percent is clinically obese, according to a 2019 World Health Organization report.
And women, who are more likely to face societal pressure to be thin, were 66 percent more likely to be obese than men, the WHO report found.
But not every Kosovar who has used Ozempic had the best experience with the drug.
"I took Ozempic on the advice of a doctor for two years but it had no effect," said 48-year-old merchant Lulzim Rrahmani, adding that three of his relatives even experienced "a negative effect of the drug".
"It was just a waste of money and time."
Given the risk of side effects, Emini-Sadiku said Ozempic was "by no means to be taken without a doctor's prescription".
Yet Kadriu said she would not be deterred, adding that she saw colleagues taking the drug "every day at work".
"I don't see any symptom that would deter me."
N.Schaad--VB